SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-044381
Filing Date
2020-07-31
Accepted
2020-07-31 21:06:03
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4418
  Complete submission text file 0001209191-20-044381.txt   6021
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Reporting) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-50549 | Film No.: 201067617
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences